110 related articles for article (PubMed ID: 36038418)
21. Indirect Toll-like receptor 5-mediated activation of conventional dendritic cells promotes the mucosal adjuvant activity of flagellin in the respiratory tract.
Fougeron D; Van Maele L; Songhet P; Cayet D; Hot D; Van Rooijen N; Mollenkopf HJ; Hardt WD; Benecke AG; Sirard JC
Vaccine; 2015 Jun; 33(29):3331-41. PubMed ID: 26003491
[TBL] [Abstract][Full Text] [Related]
22. Use of recombinant flagellin in oil-in-water emulsions enhances hemagglutinin-specific mucosal IgA production and IL-17 secreting T cells against H5N1 avian influenza virus infection.
Lai CH; Tang N; Jan JT; Huang MH; Lu CY; Chiang BL; Huang LM; Wu SC
Vaccine; 2015 Aug; 33(35):4321-9. PubMed ID: 25858857
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of mucosal and systemic immune responses elicited by GPI-0100- adjuvanted influenza vaccine delivered by different immunization strategies.
Liu H; Patil HP; de Vries-Idema J; Wilschut J; Huckriede A
PLoS One; 2013; 8(7):e69649. PubMed ID: 23936066
[TBL] [Abstract][Full Text] [Related]
24. Combined Intranasal Nanoemulsion and RIG-I Activating RNA Adjuvants Enhance Mucosal, Humoral, and Cellular Immunity to Influenza Virus.
Wong PT; Goff PH; Sun RJ; Ruge MJ; Ermler ME; Sebring A; O'Konek JJ; Landers JJ; Janczak KW; Sun W; Baker JR
Mol Pharm; 2021 Feb; 18(2):679-698. PubMed ID: 32491861
[TBL] [Abstract][Full Text] [Related]
25. Enhancement of serum and mucosal immune responses to a Haemophilus influenzae Type B vaccine by intranasal delivery.
Fernandez S; Cisney ED; Ulrich RG
Clin Vaccine Immunol; 2013 Nov; 20(11):1690-6. PubMed ID: 23986319
[TBL] [Abstract][Full Text] [Related]
26. Facilitated intranasal induction of mucosal and systemic immunity to mutans streptococcal glucosyltransferase peptide vaccines.
Smith DJ; King WF; Barnes LA; Trantolo D; Wise DL; Taubman MA
Infect Immun; 2001 Aug; 69(8):4767-73. PubMed ID: 11447149
[TBL] [Abstract][Full Text] [Related]
27. Flagellin enhances tumor-specific CD8⁺ T cell immune responses through TLR5 stimulation in a therapeutic cancer vaccine model.
Nguyen CT; Hong SH; Sin JI; Vu HV; Jeong K; Cho KO; Uematsu S; Akira S; Lee SE; Rhee JH
Vaccine; 2013 Aug; 31(37):3879-87. PubMed ID: 23831323
[TBL] [Abstract][Full Text] [Related]
28. Flagellin induces antibody responses through a TLR5- and inflammasome-independent pathway.
López-Yglesias AH; Zhao X; Quarles EK; Lai MA; VandenBos T; Strong RK; Smith KD
J Immunol; 2014 Feb; 192(4):1587-96. PubMed ID: 24442437
[TBL] [Abstract][Full Text] [Related]
29. Toll-like receptor 5 is not essential for the promotion of secretory immunoglobulin A antibody responses to flagellated bacteria.
Hashizume-Takizawa T; Yamamoto M
Microbiol Immunol; 2015 Dec; 59(12):716-23. PubMed ID: 26564803
[TBL] [Abstract][Full Text] [Related]
30. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
[TBL] [Abstract][Full Text] [Related]
31. Innate and adaptive immunity interact to quench microbiome flagellar motility in the gut.
Cullender TC; Chassaing B; Janzon A; Kumar K; Muller CE; Werner JJ; Angenent LT; Bell ME; Hay AG; Peterson DA; Walter J; Vijay-Kumar M; Gewirtz AT; Ley RE
Cell Host Microbe; 2013 Nov; 14(5):571-81. PubMed ID: 24237702
[TBL] [Abstract][Full Text] [Related]
32. Clostridium difficile flagellin FliC: Evaluation as adjuvant and use in a mucosal vaccine against Clostridium difficile.
Bruxelle JF; Mizrahi A; Hoÿs S; Collignon A; Janoir C; Péchiné S
PLoS One; 2017; 12(11):e0187212. PubMed ID: 29176760
[TBL] [Abstract][Full Text] [Related]
33. Enhanced mucosal and systemic immune response with squalane oil-containing multiple emulsions upon intranasal and oral administration in mice.
Shahiwala A; Amiji MM
J Drug Target; 2008 May; 16(4):302-10. PubMed ID: 18446609
[TBL] [Abstract][Full Text] [Related]
34. Intranasal vaccinations with the trans-sialidase antigen plus CpG Adjuvant induce mucosal immunity protective against conjunctival Trypanosoma cruzi challenges.
Giddings OK; Eickhoff CS; Sullivan NL; Hoft DF
Infect Immun; 2010 Mar; 78(3):1333-8. PubMed ID: 20048046
[TBL] [Abstract][Full Text] [Related]
35. Functional analysis of bovine TLR5 and association with IgA responses of cattle following systemic immunisation with H7 flagella.
Tahoun A; Jensen K; Corripio-Miyar Y; McAteer SP; Corbishley A; Mahajan A; Brown H; Frew D; Aumeunier A; Smith DG; McNeilly TN; Glass EJ; Gally DL
Vet Res; 2015 Feb; 46():9. PubMed ID: 25827709
[TBL] [Abstract][Full Text] [Related]
36. Enhanced humoral and mucosal immune responses after intranasal immunization with chimeric multiple antigen peptide of LcrV antigen epitopes of Yersinia pestis coupled to palmitate in mice.
Uppada SB; Bhat AA; Sah A; Donthamshetty RN
Vaccine; 2011 Nov; 29(50):9352-60. PubMed ID: 22001881
[TBL] [Abstract][Full Text] [Related]
37. Mucosal adjuvant activity of flagellin in aged mice.
Bates JT; Honko AN; Graff AH; Kock ND; Mizel SB
Mech Ageing Dev; 2008 May; 129(5):271-81. PubMed ID: 18367233
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of TLR agonists as potential mucosal adjuvants for HIV gp140 and tetanus toxoid in mice.
Buffa V; Klein K; Fischetti L; Shattock RJ
PLoS One; 2012; 7(12):e50529. PubMed ID: 23272062
[TBL] [Abstract][Full Text] [Related]
39. A Lipopolysaccharide from Pantoea Agglomerans Is a Promising Adjuvant for Sublingual Vaccines to Induce Systemic and Mucosal Immune Responses in Mice via TLR4 Pathway.
Fukasaka M; Asari D; Kiyotoh E; Okazaki A; Gomi Y; Tanimoto T; Takeuchi O; Akira S; Hori M
PLoS One; 2015; 10(5):e0126849. PubMed ID: 25978818
[TBL] [Abstract][Full Text] [Related]
40. Local mucosal immunization of self-assembled nanofibers elicits robust antitumor effects in an orthotopic model of mouse genital tumors.
Li S; Zhu W; Ye C; Sun W; Xie H; Yang X; Zhang Q; Ma Y
Nanoscale; 2020 Feb; 12(5):3076-3089. PubMed ID: 31965136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
